These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6423378)

  • 1. A longitudinal study of valproate free fraction in the specific age group at greatest risk for febrile convulsions (children below 3 years).
    Monaco F; Mele G; Meloni T; Franca V; Sotgia A; Mutani R
    Epilepsia; 1984 Apr; 25(2):240-3. PubMed ID: 6423378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic elements of sodium valproate. Use in febrile convulsions in children].
    Perignon F; Novella-Pequinot MA; Beaune P; Lenoir G
    Arch Fr Pediatr; 1983 Jan; 40(1):47-50. PubMed ID: 6407454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and toxicity of phenobarbital, primidone, and sodium valproate in the prevention of febrile convulsions, controlled by plasma levels.
    Herranz JL; Armijo JA; Arteaga R
    Epilepsia; 1984 Feb; 25(1):89-95. PubMed ID: 6420147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The free fraction of valproic acid in tears, saliva, and cerebrospinal fluid.
    Monaco F; Piredda S; Mutani R; Mastropaolo C; Tondi M
    Epilepsia; 1982 Feb; 23(1):23-6. PubMed ID: 6799283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine, and valproate during monotherapy in children.
    Herranz JL; Armijo JA; Arteaga R
    Epilepsia; 1988; 29(6):794-804. PubMed ID: 3142761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Statistics on 123 children with febrile convulsions from 1976 to 1981 with possible advantages of continuous prophylaxis with valproic acid and/or phenobarbital].
    De Zan G; Luchini P; Visentin A; Bruno F
    Pediatr Med Chir; 1982; 4(4):407-12. PubMed ID: 6820499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reversible neuropsychological deterioration associated with valproate].
    Vaquerizo J; Gómez Martín H; González Iglesias E; Cardesa JJ
    Rev Neurol; 1995; 23(119):148-50. PubMed ID: 8548612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium valproate versus phenobarbital in the prophylactic treatment of febrile convulsions in childhood.
    Lee K; Melchior JC
    Eur J Pediatr; 1981 Oct; 137(2):151-3. PubMed ID: 6796420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful prophylaxis against febrile convulsions with valproic acid or phenobarbitone.
    Wallace SJ; Smith JA
    Br Med J; 1980 Feb; 280(6211):353-4. PubMed ID: 6767518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous sodium valproate or phenobarbitone in the prevention of 'simple' febrile convulsions. Comparison by a double-blind trial.
    Ngwane E; Bower B
    Arch Dis Child; 1980 Mar; 55(3):171-4. PubMed ID: 6770760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DPA and clonazepam activity in febrile convulsions: preliminary results].
    Steardo L; Florio C; Sorge F; Steardo R
    Boll Soc Ital Biol Sper; 1980 Jun; 56(11):1187-91. PubMed ID: 6255970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factors in recurrent febrile seizures].
    Martín-Fernández JJ; Moltó-Jordà JM; Villaverde R; Salmerón P; Prieto-Muñoz I; Fernández-Barreiro A
    Rev Neurol; 1996 Dec; 24(136):1520-4. PubMed ID: 9064166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent distribution volumes of total and unbound valproate in guinea-pigs: consequence of non-linear plasma protein binding.
    Yu HY; Shen YZ
    Biopharm Drug Dispos; 1996 Apr; 17(3):237-47. PubMed ID: 8983398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium valproate in the prophylaxis of simple febrile convulsions.
    Williams AJ; Evans-Jones LG; Kindley AD; Groom PJ
    Clin Pediatr (Phila); 1979 Jul; 18(7):426-30. PubMed ID: 378504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo determination of valproate binding constants during sole and multi-drug therapy.
    Scheyer RD; Cramer JA; Toftness BR; Hochholzer JM; Mattson RH
    Ther Drug Monit; 1990 Mar; 12(2):117-23. PubMed ID: 2107606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of sodium dipropylacetate in the prevention of recurrences of febrile convulsions].
    Cavazzuti GB
    Riv Neurol; 1977; 47(2):156-8. PubMed ID: 325627
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the pharmacokinetics of total and free valproate in mono- and bitherapy with carbamazepine in epileptic children and adolescents.
    Steinborn B; Galas-Zgorzalewicz B
    Folia Neuropathol; 2002; 40(2):97-100. PubMed ID: 12230261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Febrile convulsions: intellectual progress in relation to anticonvulsant therapy and to recurrence of fits.
    Smith JA; Wallace SJ
    Arch Dis Child; 1982 Feb; 57(2):104-7. PubMed ID: 6802077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Simple and Rapid Method to Measure Free Fraction of Valproic Acid in Plasma Using Ultrafiltration and Ultra High Performance Liquid Chromatography-Mass Spectroscopy: Application to Therapeutic Drug Monitoring.
    Xu S; Chen Y; Zhao M; Zhao L
    Ther Drug Monit; 2017 Oct; 39(5):575-579. PubMed ID: 28700449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration of valproate and its active metabolites into cerebrospinal fluid of children with epilepsy.
    Löscher W; Nau H; Siemes H
    Epilepsia; 1988; 29(3):311-6. PubMed ID: 3131137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.